Aiforia collaborates with PathAI to broaden access to AI-driven diagnostics
recent articles
Artificial Intelligence in Pathology – Has It’s Time Come?
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Business
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Digital Pathology News
- Education
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Management & Operations
- Molecular Pathology
- New Digital Imaging Technologies
- Pathology News
- Vendor products
- Whole slide
Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...
Gestalt: Voicebrook's integration with Gestalt represents the industry's first fully speech-enabled digital pathology solution. Roslyn Heights, NY, Sept. 11, 2025 -- Voicebrook, Inc., the leading provider of pathology reporting solutions,...
Proscia: AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform PHILADELPHIA, PA – September 16, 2025 – Proscia®, a pathology AI company, today...
The latest from the Indica Labs blog Overview: The Clinical Trials Module in HALO AP Platforms The Clinical Trials module in HALO AP®, a CE-IVDR marked and AI-powered platform for primary diagnosis, and HALO AP Dx, an FDA-cleared...
The Aiforia® Lymph Node Metastasis AI model supports the detection and quantification of metastases of breast cancer, melanoma, and colorectal cancer in lymph nodes from whole slide images. Aiforia Technologies Plc, Press Release, September...
Upcoming Aiforia webinar Evaluation of HER2-low and ultralow status of advanced breast carcinomas Monday, September 29, 2025 3-4pm CEST | 9-10 am EDT REGISTER NOW Join this webinar to discover how digital pathology with AI evaluation...
